Comments
Loading...
NovoCure Earnings Estimates, EPS & Revenue | NASDAQ:NVCR | Benzinga
NovoCure reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$-0.380
Quarterly Revenue Estimate
$152.31M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$605.22M
Analyze the earnings history of NovoCure using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVCR | NovoCure | -$0.36 | -$0.38 | — | — | $138.50M | $152.31M | — | — | 05/01/2025 | Get Alert |
| NVCR | NovoCure | -$0.45 | -$0.34 | -$0.61 | -79.41% | $133.78M | $161.30M | $161.27M | -0.02% | 02/27/2025 | Get Alert |
| NVCR | NovoCure | -$0.46 | -$0.33 | -$0.28 | 15.15% | $127.32M | $143.95M | $155.09M | 7.74% | 10/30/2024 | Get Alert |
| NVCR | NovoCure | -$0.54 | -$0.41 | -$0.31 | 24.39% | $126.05M | $135.82M | $150.36M | 10.70% | 07/25/2024 | Get Alert |
| NVCR | NovoCure | -$0.50 | -$0.42 | -$0.36 | 14.29% | $122.18M | $131.45M | $138.50M | 5.37% | 05/02/2024 | Get Alert |
| NVCR | NovoCure | -$0.36 | -$0.52 | -$0.45 | 13.46% | $128.43M | $131.19M | $133.78M | 1.98% | 02/22/2024 | Get Alert |
| NVCR | NovoCure | -$0.25 | -$0.52 | -$0.46 | 11.54% | $131.00M | $128.76M | $127.32M | -1.12% | 10/26/2023 | Get Alert |
| NVCR | NovoCure | -$0.23 | -$0.50 | -$0.54 | -8.00% | $140.87M | $124.26M | $126.05M | 1.44% | 07/27/2023 | Get Alert |
| NVCR | NovoCure | -$0.04 | -$0.32 | -$0.50 | -56.25% | $137.55M | $127.28M | $122.18M | -4.01% | 05/04/2023 | Get Alert |
| NVCR | NovoCure | -$0.25 | -$0.30 | -$0.36 | -20.00% | $133.21M | $128.25M | $128.43M | 0.14% | 02/23/2023 | Get Alert |
| NVCR | NovoCure | -$0.13 | -$0.26 | -$0.25 | 3.85% | $133.61M | $131.94M | $131.00M | -0.71% | 10/27/2022 | Get Alert |
| NVCR | NovoCure | -$0.14 | -$0.15 | -$0.23 | -53.33% | $133.52M | $134.99M | $140.87M | 4.35% | 07/28/2022 | Get Alert |
| NVCR | NovoCure | -$0.04 | -$0.18 | -$0.04 | 77.78% | $134.69M | $134.08M | $137.55M | 2.59% | 04/28/2022 | Get Alert |
| NVCR | NovoCure | $0.04 | -$0.10 | -$0.25 | -150.00% | $143.95M | $135.42M | $133.21M | -1.63% | 02/24/2022 | Get Alert |
| NVCR | NovoCure | $0.09 | -$0.07 | -$0.13 | -85.71% | $132.66M | $141.76M | $133.61M | -5.75% | 10/28/2021 | Get Alert |
| NVCR | NovoCure | $0.02 | $0.01 | -$0.14 | -1500.00% | $115.92M | $141.89M | $133.52M | -5.90% | 07/29/2021 | Get Alert |
| NVCR | NovoCure | $0.04 | $0.02 | -$0.04 | -300.00% | $101.83M | $139.36M | $134.69M | -3.35% | 04/29/2021 | Get Alert |
| NVCR | NovoCure | $0.04 | $0.12 | $0.04 | -66.67% | $99.23M | $141.29M | $143.95M | 1.88% | 02/25/2021 | Get Alert |
| NVCR | NovoCure | $0.02 | $0.03 | $0.09 | 200.00% | $92.06M | $120.24M | $132.66M | 10.33% | 10/29/2020 | Get Alert |
| NVCR | NovoCure | -$0.01 | — | $0.02 | — | $86.71M | $106.03M | $115.92M | 9.33% | 07/30/2020 | Get Alert |
| NVCR | NovoCure | -$0.13 | $0.02 | $0.04 | 100.00% | $73.31M | $102.15M | $101.83M | -0.32% | 04/30/2020 | Get Alert |
NovoCure (NVCR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $-0.61 | $-0.34 | -79.4 % |
| Q3 | 2024-10-30 | $-0.28 | $-0.33 | 15.2 % |
| Q2 | 2024-07-25 | $-0.31 | $-0.41 | 24.4 % |
| Q1 | 2024-05-02 | $-0.36 | $-0.42 | 14.3 % |
NovoCure (NVCR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $161.27M | $161.30M | -0.02 % |
| Q3 | 2024-10-30 | $155.10M | $143.95M | 7.74 % |
| Q2 | 2024-07-25 | $150.36M | $135.82M | 10.7 % |
| Q1 | 2024-05-02 | $138.50M | $131.45M | 5.37 % |
FAQ
When is NovoCure (NASDAQ:NVCR) reporting earnings?
NovoCure (NVCR) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for NovoCure (NASDAQ:NVCR)?
The Actual EPS was $-0.61, which missed the estimate of $-0.34.
What were NovoCure’s (NASDAQ:NVCR) revenues?
The Actual Revenue was $161.3M, which missed the estimate of $161.3M.
Browse earnings estimates, EPS, and revenue on all stocks.